Bridgefront Capital’s Myriad Genetics MYGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
Sell
-16,400
Closed -$145K 762
2025
Q1
$145K Buy
+16,400
New +$145K 0.04% 558